Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuri Hori

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cureus|October 30, 2024
Gilteritinib-Induced Hypopituitarism: A Case ReportYuri Hori, Yosuke Okada, Satomi Sonoda, et al.
Journal of Diabetes Investigation|December 27, 2023
Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trialKenichi Tanaka, Yosuke Okada, Saeko Umezu, et al.
Frontiers in Neuroscience|January 1, 2021
Anti-sortilin1 Antibody Up-Regulates Progranulin <i>via</i> Sortilin1 Down-RegulationShuuichi Miyakawa, Hiroyuki Sakuma, Dnyaneshwar Warude, et al.
Bioorganic & Medicinal Chemistry|January 3, 2018
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitorsAkira Kaieda, Masashi Takahashi, Takafumi Takai, et al.
Chemmedchem|April 5, 2019
Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1Akira Kaieda, Masashi Takahashi, Hiromi Fukuda, et al.
Chemmedchem|November 8, 2019
Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]Pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 2Akira Kaieda, Masashi Takahashi, Hiromi Fukuda, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cureus|October 30, 2024
Gilteritinib-Induced Hypopituitarism: A Case ReportYuri Hori, Yosuke Okada, Satomi Sonoda, et al.
Journal of Diabetes Investigation|December 27, 2023
Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trialKenichi Tanaka, Yosuke Okada, Saeko Umezu, et al.
Frontiers in Neuroscience|January 1, 2021
Anti-sortilin1 Antibody Up-Regulates Progranulin <i>via</i> Sortilin1 Down-RegulationShuuichi Miyakawa, Hiroyuki Sakuma, Dnyaneshwar Warude, et al.
Bioorganic & Medicinal Chemistry|January 3, 2018
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitorsAkira Kaieda, Masashi Takahashi, Takafumi Takai, et al.
Chemmedchem|April 5, 2019
Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1Akira Kaieda, Masashi Takahashi, Hiromi Fukuda, et al.
Chemmedchem|November 8, 2019
Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]Pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 2Akira Kaieda, Masashi Takahashi, Hiromi Fukuda, et al.
Pageof 1